Synapse - Works

Results (2639)

Comprehensive genomic profiling (CGP) of angioimmunoblastic T-cell lymphoma (AITL) to prospectively inform diagnosis and clinical management

Meeting Abstract

Morley, S.; He, J.; Intlekofer, A. M.; Bailey, M.; Nahas, M.; Lipson, D.; Yelensky, R.; Ross, J.; Ali, S.; Erlich, R.; more...
Blood (2015)

Fulltext@MSK | Save

Successful treatment of peripheral T-cell lymphoma with allogeneic stem cell transplantation: A large single-center experience

Meeting Abstract

Mehta-Shah, N.; Chou, J.; Maloy, M.; Zhang, Z. G.; Moskowitz, A. J.; Moskowitz, C. H.; Barker, J. N.; Giralt, S.; Perales, M. A.; Horwitz, S. M.; more...
Blood (2015)

Fulltext@MSK | Save

A prospective study of allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma

Meeting Abstract

Perales, M. A.; Cho, C.; Eaton, A.; Moskowitz, A. J.; Nguyen, V.; Gonzales-Dadiz, A. M. R.; Devlin, S.; Giralt, S. A.; Jakubowski, A. A.; Matasar, M. J.; more...
Blood (2015)

Fulltext@MSK | Save

Phase 1/1b study of the novel immunotoxin MT-3724 in relapsed/refractory non-Hodgkin's B-cell lymphoma (NHL)

Meeting Abstract

Hamlin, P. A.; Diefenbach, C. S.; Valacer, D. J.; Higgins, J.; Fanale, M. A.
Blood (2015)

Fulltext@MSK | Save

Results from a phase 1/2, open-label, dose-finding study of pralatrexate and oral bexarotene in patients with relapsed/refractory cutaneous T-cell lymphoma

Meeting Abstract

Duvic, M.; Horwitz, S. M.; Kim, Y. H.; Zinzani, P. L.; Bhat, G.; Sharma, P.; Yancik, S.
Blood (2015)

Fulltext@MSK | Save

Clinical and correlative results of a phase 1 study of cerdulatinib (PRT062070) a dual SYK/JAK inhibitor in patients with relapsed/refractory B cell malignancies

Meeting Abstract

Hamlin, P. A.; Flinn, I.; Wagner-Johnston, N.; Burger, J. A.; Michelson, G.; Pandey, A.; Birrell, M.; Coffey, G. P.; Leeds, J. M.; Curnutte, J. T.; more...
Blood (2015)

Fulltext@MSK | Save

Five-year survival data demonstrating durable responses from a pivotal phase 2 study of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma

Meeting Abstract

Chen, R.; Gopal, A. K.; Smith, S. E.; Ansell, S.; Rosenblatt, J. D.; Savage, K. J.; Connors, J. M.; Engert, A.; Larsen, E. K.; Huebner, D.; more...
Blood (2015)

Fulltext@MSK | Save

Differences in patients with progressive versus non-progressive AML, CLL, or NHL: Implications for proposed bundled payment strategies

Meeting Abstract

Byfield, S. D.; Engel-Nitz, N.; Bancroft, T.; Anderson, A. J.; Reyes, C.; Ravelo, A.; Ogale, S.; Chen, M.; Matasar, M. J.
Blood (2015)

Fulltext@MSK | Save

Patterns of lymphocytosis in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) treated with idelalisib

Meeting Abstract

Brown, J. R.; Cheson, B. D.; Furman, R. R.; Ghia, P.; Hallek, M.; Hillmen, P.; O'Brien, S. M.; Sharman, J. P.; Dubowy, R. L.; Velasco, B.; more...
Blood (2015)

Fulltext@MSK | Save

Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration

Meeting Abstract

Cheah, C. Y.; Broeckelmann, P. J.; Moskowitz, A. J.; Engert, A.; Jerkeman, M.; El-Galaly, T. C.; Vose, J.; Villa, D.; Connors, J. M.; Feldman, T.; more...
Blood (2015)

Fulltext@MSK | Save